RU93058535A - TABLET CONTAINING KOLESTIPOL HYDROCHLORIDE AND METHOD FOR PRODUCING IT - Google Patents
TABLET CONTAINING KOLESTIPOL HYDROCHLORIDE AND METHOD FOR PRODUCING ITInfo
- Publication number
- RU93058535A RU93058535A RU93058535/14A RU93058535A RU93058535A RU 93058535 A RU93058535 A RU 93058535A RU 93058535/14 A RU93058535/14 A RU 93058535/14A RU 93058535 A RU93058535 A RU 93058535A RU 93058535 A RU93058535 A RU 93058535A
- Authority
- RU
- Russia
- Prior art keywords
- kolestipol
- hydrochloride
- producing
- tablet containing
- new
- Prior art date
Links
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 229920002911 Colestipol Polymers 0.000 claims 1
- 229960002577 Colestipol Hydrochloride Drugs 0.000 claims 1
- GACQNVJDWUAPFY-UHFFFAOYSA-N N'-[2-[2-(2-aminoethylamino)ethylamino]ethyl]ethane-1,2-diamine;hydrochloride Chemical compound Cl.NCCNCCNCCNCCN GACQNVJDWUAPFY-UHFFFAOYSA-N 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
Claims (1)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US72504491A | 1991-07-03 | 1991-07-03 | |
US07/725,044 | 1991-07-03 | ||
US07/725044 | 1991-07-03 | ||
PCT/US1992/005066 WO1993000915A1 (en) | 1991-07-03 | 1992-06-23 | Colestipol hydrochloride high-content tablets |
Publications (2)
Publication Number | Publication Date |
---|---|
RU93058535A true RU93058535A (en) | 1996-09-20 |
RU2108090C1 RU2108090C1 (en) | 1998-04-10 |
Family
ID=24912923
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU93058535A RU2108090C1 (en) | 1991-07-03 | 1992-06-23 | Tablet containing cholesterol hydrochloride and method for its production |
Country Status (18)
Country | Link |
---|---|
US (1) | US5490987A (en) |
EP (1) | EP0592594B1 (en) |
JP (1) | JP3313710B2 (en) |
KR (1) | KR100240362B1 (en) |
AT (1) | ATE173931T1 (en) |
AU (1) | AU669664B2 (en) |
CA (1) | CA2110166C (en) |
CZ (1) | CZ286958B6 (en) |
DE (1) | DE69227773T2 (en) |
DK (1) | DK0592594T3 (en) |
ES (1) | ES2124736T3 (en) |
FI (1) | FI106843B (en) |
HU (1) | HU222242B1 (en) |
NO (1) | NO307686B1 (en) |
PL (1) | PL169045B1 (en) |
RU (1) | RU2108090C1 (en) |
SK (1) | SK281920B6 (en) |
WO (1) | WO1993000915A1 (en) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2129079C (en) * | 1993-08-03 | 2006-01-17 | Tatsuo Nomura | Orally administrable cholesterol lowering agent |
NZ503086A (en) * | 1997-08-29 | 2002-03-01 | Upjohn Co | An orally administrable pharmaceutical composition comprising an inner core and two outer layers, which render it substantially free of unpleasant tastes |
CN1202812C (en) * | 1999-10-19 | 2005-05-25 | 基酶有限公司 | Direct comperession polymer tablet core |
US6733780B1 (en) | 1999-10-19 | 2004-05-11 | Genzyme Corporation | Direct compression polymer tablet core |
GB0123400D0 (en) | 2001-09-28 | 2001-11-21 | Novartis Ag | Organic compounds |
US20040109889A1 (en) * | 2002-12-04 | 2004-06-10 | Bunick Frank J. | Surface treatment composition for soft substrates |
EP1699442A2 (en) * | 2003-12-31 | 2006-09-13 | Genzyme Corporation | Enteric coated aliphatic amine polymer bile acid sequestrants |
US7985418B2 (en) | 2004-11-01 | 2011-07-26 | Genzyme Corporation | Aliphatic amine polymer salts for tableting |
CA2620406A1 (en) | 2005-09-02 | 2007-03-08 | Genzyme Corporation | Method for removing phosphate and polymer used therefore |
HUE026628T2 (en) | 2005-09-15 | 2016-06-28 | Genzyme Corp | Sachet formulation for amine polymers |
US7964182B2 (en) * | 2006-09-01 | 2011-06-21 | USV, Ltd | Pharmaceutical compositions comprising phosphate-binding polymer |
KR20090051240A (en) * | 2006-09-01 | 2009-05-21 | 유에스브이 리미티드 | Process for the preparation of sevelamer hydrochloride and formulation thereof |
JP2010504975A (en) | 2006-09-29 | 2010-02-18 | ゲンズイメ コーポレーション | Amide dendrimer composition |
BRPI0720234A2 (en) | 2006-12-14 | 2013-12-24 | Genzyme Corp | PHARMACEUTICAL COMPOSITION |
WO2010041268A2 (en) * | 2008-09-02 | 2010-04-15 | Usv Limited | Crosslinked polymers |
KR20110119714A (en) * | 2009-01-22 | 2011-11-02 | 유에스브이 리미티드 | Pharmaceutical compositions comprising phosphate-binding polymer |
US9763928B2 (en) * | 2012-02-10 | 2017-09-19 | Niconovum Usa, Inc. | Multi-layer nicotine-containing pharmaceutical composition |
MA41202A (en) | 2014-12-18 | 2017-10-24 | Genzyme Corp | CROSS-LINKED POLYDIALLYMINE COPOLYMERS FOR THE TREATMENT OF TYPE 2 DIABETES |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3803237A (en) * | 1969-11-03 | 1974-04-09 | Upjohn Co | Reaction products of polyethylenepolyamines and chlorohydrins or epoxy containing compounds |
US3692895A (en) * | 1970-09-08 | 1972-09-19 | Norman A Nelson | Method of reducing hypercholesteremia in humans employing a copolymer of polyethylenepolyamine and a bifunctional substance, such as epichlorohydria |
ZA804914B (en) * | 1979-08-29 | 1981-08-26 | Rohm & Haas | The production of powdered resin and the powdered resin so produced |
US4439419A (en) * | 1980-02-20 | 1984-03-27 | The Upjohn Company | Method of treating gastric hyperacidity in humans employing a copolymer of polyethylenepolyamine and a bifunctional substance as epichlorhydrin |
US4404346A (en) * | 1980-08-05 | 1983-09-13 | Rohm And Haas Company | Production of powdered resin and the powdered resin so produced |
US4631305A (en) * | 1985-03-22 | 1986-12-23 | The Upjohn Company | Polymeric material as a disintegrant in a compressed tablet |
DE68907721T2 (en) * | 1988-06-24 | 1993-11-18 | Upjohn Co | MILLED COLESTIPOL HYDROCHLORIDE. |
IE63242B1 (en) * | 1988-06-24 | 1995-04-05 | Abbott Lab | Pharmaceutical granules and tablets made therefrom |
DE68911146T2 (en) * | 1988-08-26 | 1994-04-14 | Upjohn Co | FINE-GRAINED COLESTIPOL HYDROCHLORIDE. |
-
1992
- 1992-06-23 EP EP92915578A patent/EP0592594B1/en not_active Expired - Lifetime
- 1992-06-23 US US08/175,412 patent/US5490987A/en not_active Expired - Lifetime
- 1992-06-23 AU AU22933/92A patent/AU669664B2/en not_active Expired
- 1992-06-23 WO PCT/US1992/005066 patent/WO1993000915A1/en active IP Right Grant
- 1992-06-23 CZ CZ19932826A patent/CZ286958B6/en not_active IP Right Cessation
- 1992-06-23 JP JP50222193A patent/JP3313710B2/en not_active Expired - Lifetime
- 1992-06-23 CA CA002110166A patent/CA2110166C/en not_active Expired - Lifetime
- 1992-06-23 HU HU9400004A patent/HU222242B1/en active IP Right Grant
- 1992-06-23 ES ES92915578T patent/ES2124736T3/en not_active Expired - Lifetime
- 1992-06-23 DE DE69227773T patent/DE69227773T2/en not_active Expired - Lifetime
- 1992-06-23 PL PL92301951A patent/PL169045B1/en unknown
- 1992-06-23 KR KR1019930704111A patent/KR100240362B1/en not_active IP Right Cessation
- 1992-06-23 RU RU93058535A patent/RU2108090C1/en active
- 1992-06-23 DK DK92915578T patent/DK0592594T3/en active
- 1992-06-23 AT AT92915578T patent/ATE173931T1/en active
- 1992-06-23 SK SK1-94A patent/SK281920B6/en not_active IP Right Cessation
-
1993
- 1993-12-30 FI FI935943A patent/FI106843B/en not_active IP Right Cessation
-
1994
- 1994-01-03 NO NO940008A patent/NO307686B1/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU93058535A (en) | TABLET CONTAINING KOLESTIPOL HYDROCHLORIDE AND METHOD FOR PRODUCING IT | |
HUT59306A (en) | Process for producing pharmaceutical compositions comprising l-carnitine | |
HUP9800417A3 (en) | 5-substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)-indoles and 5-substituted-3-(piperidin-4-yl)-1h-indoles, their use as new 5-ht agonists, pharmaceutical compositions containing these compounds | |
CA2166483A1 (en) | New Pharmaceutical Formulation | |
IL94404A0 (en) | Oxadiazole and its salts,their preparation and pharmaceutical compositions containing them | |
IL91404A0 (en) | Substituted 4-azatricyclo(22.3.1.0 4,9)octacos-18-ene derivations,their preparation and pharmaceutical compositions containing them | |
CA2193337A1 (en) | 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients | |
EE200000320A (en) | Novel compounds | |
CA2348086A1 (en) | Controlled-release pharmaceutical formulations | |
ZA965294B (en) | Substituted 4-phenylaminothiazoles, their process of preparation and the pharmaceutical compositions containing them. | |
CA2110166A1 (en) | Tableting of colestipol hydrochloride | |
CA2001572A1 (en) | Compositions for treating tobacco withdrawal symptoms | |
HUT61554A (en) | Process for producing 2,8-dioxabicyclo/3.2.1/octane derivatives and pharmaceutical compositions comprising same | |
DE69907926D1 (en) | 1,2,4-TRIAZOL-3-THION COMPOUNDS | |
CA2220019A1 (en) | Pharmaceutical composition containing tiagabine hydrochloride and the process for its preparation | |
CA2027814A1 (en) | Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds | |
ES8200678A1 (en) | Dibenzazepine derivatives, their production and pharmaceutical compositions containing them. | |
IL95210A0 (en) | 14,17alpha-etheno-and-ethanoestratrienes,process for the preparation thereof and pharmaceutical compositions containing the same | |
IT1230780B (en) | PROCEDURE FOR THE PREPARATION OF 1,2 DICHLOR 1,1,2 TRIFLUOROETHANE. | |
CA2066532A1 (en) | Pharmaceutical compositions | |
CA2002182A1 (en) | Compositions for treating the premenstrual or late luteal phase syndrome and methods for their use | |
AU5194190A (en) | Magnesium folates, process for their preparation and pharmaceutical compositions | |
FR2652590B1 (en) | EXTRACELLULAR EXOPOLYMER, PROCESS FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME. | |
IL93759A0 (en) | Platinum complexes,their preparation and pharmaceutical compositions which contain them | |
IL97321A0 (en) | Diamine derivatives,their manufacture and pharmaceutical compositions containing them |